BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
273 hedge funds and large institutions have $7.92B invested in bluebird bio in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 81 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
273
Holders Change
-15
Holders Change %
-5.21%
% of All Funds
5.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
106
Reduced
81
Closed
42
Calls
$100M
Puts
$131M
Net Calls
-$31M
Net Calls Change
-$84.9M
Top Buyers
| 1 |
Sands Capital Management
Arlington,
Virginia
|
+$141M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$121M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$53.1M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$48.9M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$26.9M |
